Stock screener

LXEO

Conviction 20HealthcareScan · Fri, Oct 2, 2026

Lexeo Therapeutics, Inc. (LXEO) closed at $3.53 (-2.49%) on Oct 2, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 37, RS Rating 19, -66.7% from its 52-week high, -63.2% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

LXEO$3.53-2.49%
ResistanceSupportVol 14Insider sell
63 bars
3
Vol MA14 2.15M
Jul 7Jul 23Aug 11Aug 27Sep 16Oct 2
Lexeo Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.lexeotx.com ↗
Price3.53
Change-2.49%
Gap+1.52%
Rel volume2.04×
Avg volume1.75M
Avg $ vol6.51M
SMA 203.95
SMA 504.42
SMA 2005.88
Price vs 50-19.95%
Price vs 200-39.77%
MA stackbearish
50/200 cross—
Supertrenddown · 3.99
RSI (14)37
MACD hist-0.03
MACD cross—
Stoch %K / %D40 / 37
ADX (14)25
+DI / −DI16 / 25
RSI divergence—
MACD divergence—
ATR %8.11%
ADR %7.00%
52w high10.63
52w low3.14
From 52w high-66.70%
Above 52w low+12.74%
New 52w highNo
SqueezeOff
Bollinger width49.64%
%B0.29
Donchian pos27.86%
Donchian high4.99
Donchian low2.98
AVWAP (52w high)5.65
vs AVWAP high-37.40%
AVWAP (52w low)3.43
vs AVWAP low+3.12%
OBV trendDown
Chaikin MF (20)-0.18
Today vs 20d2.04×
Avg vol (14d)2.2M
Avg vol (20d)1.75M
Avg $ vol (20d)6.51M
Market cap290.44M
RS Rating19 / 99
RS 3m (vs SPY)-25.49%
RS 6m (vs SPY)-55.47%
RS line new highNo
Trend template0/8
Technical rank16.1
1 week+6.95%
1 month-25.94%
3 months-23.04%
6 months-38.11%
1 year-46.69%
YTD-63.16%
P/E-2.91
P/B1.24
P/S444.10
P/FCF-2.94
EPS-1.86
Div yield—
ROE-42.53%
ROA-39.22%
Debt/Eq—
Current13.89
EV/EBITDA-1.81
Gross margin—
Net margin—
Rev growth—
EPS growth-1.66%
Price target18.00
Target upside408.47%
Analyst ratingBuy
Institutional118.44%
Ent. value197.61M
Revenue531K
Net income-25.87M
Gross profit—
Free cash flow-98.96M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out78.52M
Employees59
ListedFri, Nov 3, 2023
Free float76.64M
Float %97.6%
Short interest20.49M
Days to cover26.8d
Short volume50.0%
Squeeze score87 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.30 vs −$0.30
Last surprise0.0% beat
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank16.1 / 100
Group rank14 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.24
Support3.50
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in LXEO

All disclosures →
No recent disclosed trades by Congress in LXEO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LXEO · open-market 3 sells

InsiderSideShares
Townsend Richard Nolan
Chief Executive Officer · Common Stock · 2026-08-18
Sell3.35K
Otero Jose Manuel
Chief Operating Officer · Common Stock · 2026-08-18
Sell1.3K
Tamayo Louis Edward
Chief Financial Officer · Common Stock · 2026-08-18
Sell4.12K
Altschuler Steven
Director · Stock Option (right to buy) · 2026-06-25
Grant35K
Agger Mette Kirstine
Director · Stock Option (right to buy) · 2026-06-25
Grant35K
CHOLMONDELEY PAULA H
Director · Stock Option (right to buy) · 2026-06-25
Grant35K
COOPERSTONE BRENDA
Director · Stock Option (right to buy) · 2026-06-25
Grant35K
DIAZ REINALDO M
Director · Stock Option (right to buy) · 2026-06-25
Grant35K
Van Hauwermeiren Timothy
Director · Stock Option (right to buy) · 2026-06-25
Grant35K
Tanguler Tolga
Director · Stock Option (right to buy) · 2026-06-25
Grant35K

SEC filings

EDGAR filings in LXEO · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.